Quant Ratios & Signal Review For Aradigm Corporation (NasdaqCM:ARDM)

Quant Ratios & Signal Review For Aradigm Corporation (NasdaqCM:ARDM)

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics.  First off we’ll take a look at the Price to Cash Flow ratio of Aradigm Corporation (NasdaqCM:ARDM).  The firm currently has a P/CF ratio of -1.002058. This is the current Price divided by Cash Flow Per Share for the trailing twelve months. Cash Flow is defined as Income After Taxes minus […]

Read More ˃
Which Direction is the Data Pointing to For Clarocity Corporation (TSXV:CLY)?

Which Direction is the Data Pointing to For Clarocity Corporation (TSXV:CLY)?

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics.  First off we’ll take a look at the Price to Cash Flow ratio of Clarocity Corporation (TSXV:CLY).  The firm currently has a P/CF ratio of -2.566298. This is the current Price divided by Cash Flow Per Share for the trailing twelve months. Cash Flow is defined as Income After Taxes minus […]

Read More ˃
An Inside Look at Bioverativ Inc. (NasdaqGS:BIVV)’s Quant Data

An Inside Look at Bioverativ Inc. (NasdaqGS:BIVV)’s Quant Data

The Price to Cash Flow for Bioverativ Inc. (NasdaqGS:BIVV) is 25.010965. The price to cash flow formula is a useful tool investors can use in order to determine the value of a company. Generally, a higher P/CF ratio indicates that the company is less capital demanding and the lesser price to cash flow indicates that the company is more capital demanding. Formula: Price to Cash Flow = Current Stock Price/ Cash […]

Read More ˃
Are Investors Finding Value in AcelRx Pharmaceuticals, Inc. (NasdaqGM:ACRX)?

Are Investors Finding Value in AcelRx Pharmaceuticals, Inc. (NasdaqGM:ACRX)?

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics.  First off we’ll take a look at the Price to Cash Flow ratio of AcelRx Pharmaceuticals, Inc. (NasdaqGM:ACRX).  The firm currently has a P/CF ratio of -2.561826. This is the current Price divided by Cash Flow Per Share for the trailing twelve months. Cash Flow is defined as Income After Taxes […]

Read More ˃
Valuation Metrics in Focus For Ciena Corporation (NYSE:CIEN)

Valuation Metrics in Focus For Ciena Corporation (NYSE:CIEN)

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics.  First off we’ll take a look at the Price to Cash Flow ratio of Ciena Corporation (NYSE:CIEN).  The firm currently has a P/CF ratio of 13.610540. This is the current Price divided by Cash Flow Per Share for the trailing twelve months. Cash Flow is defined as Income After Taxes minus […]

Read More ˃